LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours.

    Thaler, Martin / Khosravi, Ismail / Leithner, Andreas / Papagelopoulos, Panayiotis J / Ruggieri, Pietro

    International orthopaedics

    2020  Volume 44, Issue 8, Page(s) 1503–1509

    Abstract: ... COVID-19) pandemic on musculoskeletal tumor service by conducting an online survey of physicians ... potential disruption of healthcare (12 questions), and influence of the COVID-19 pandemic on the particular ... radiotherapy, chemotherapy) for malignancies of the musculoskeletal system. Delaying or stopping ...

    Abstract Background: The aim of the current study was to evaluate the impact of the coronavirus disease (COVID-19) pandemic on musculoskeletal tumor service by conducting an online survey of physicians.
    Methods: The survey was conducted among the members of the ISOLS (International Society of Limb Salvage) and the EMSOS (European Musculo-Skeletal Oncology Society). The survey consisted of 20 questions (single, multiple-response, ranked): origin and surgical experience of the participant (four questions), potential disruption of healthcare (12 questions), and influence of the COVID-19 pandemic on the particular physician (four questions). A matrix with four different response options was created for the particular surgical procedures).
    Results: One hundred forty-nine physicians from five continents completed the survey. Of the respondents, 20.1% and 20.7% stated that surgery for life-threatening sarcomas were stopped or delayed, respectively. Even when the malignancy was expected to involve infiltration of a neurovascular bundle or fracture of a bone, still 13.8% and 14.7% of the respondents, respectively, stated that surgery was not performed. In cases of pending fractures of bone tumors, 37.5 to 46.2% of operations were canceled.
    Conclusion: The SARS-CoV-2 pandemic caused a significant reduction in healthcare (surgery, radiotherapy, chemotherapy) for malignancies of the musculoskeletal system. Delaying or stopping these treatments is life-threatening or can cause severe morbidity, pain, and loss of function. Although the coronavirus disease causes severe medical complications, serious collateral damage including death due to delayed or untreated sarcomas should be avoided.
    MeSH term(s) Adolescent ; Adult ; Betacoronavirus ; COVID-19 ; Child ; Child, Preschool ; Coronavirus Infections/complications ; Humans ; Infant ; Middle Aged ; Pandemics ; Pneumonia, Viral/complications ; SARS-CoV-2 ; Sarcoma/therapy ; Surveys and Questionnaires ; Young Adult
    Keywords covid19
    Language English
    Publishing date 2020-05-26
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 80384-4
    ISSN 1432-5195 ; 0341-2695
    ISSN (online) 1432-5195
    ISSN 0341-2695
    DOI 10.1007/s00264-020-04636-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours

    Thaler, Martin / Khosravi, Ismail / Leithner, Andreas / Papagelopoulos, Panayiotis J. / Ruggieri, Pietro

    International Orthopaedics

    2020  Volume 44, Issue 8, Page(s) 1503–1509

    Keywords Orthopedics and Sports Medicine ; covid19
    Language English
    Publisher Springer Science and Business Media LLC
    Publishing country us
    Document type Article ; Online
    ZDB-ID 80384-4
    ISSN 1432-5195 ; 0341-2695
    ISSN (online) 1432-5195
    ISSN 0341-2695
    DOI 10.1007/s00264-020-04636-4
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours

    THALER, M. / KHOSRAVI, I. / LEITHNER, A. / PAPAGELOPOULOS, PJ. / RUGGIERI, P.

    2020  

    Abstract: ... COVID-19) pandemic on musculoskeletal tumor service by conducting an online survey of physicians ... potential disruption of healthcare (12 questions), and influence of the COVID-19 pandemic on the particular ... for malignancies of the musculoskeletal system. Delaying or stopping these treatments is life-threatening or ...

    Abstract Background The aim of the current study was to evaluate the impact of the coronavirus disease (COVID-19) pandemic on musculoskeletal tumor service by conducting an online survey of physicians. Methods The survey was conducted among the members of the ISOLS (International Society of Limb Salvage) and the EMSOS (EuropeanMusculo-Skeletal Oncology Society). The survey consisted of 20 questions (single,multiple-response, ranked): origin and surgical experience of the participant (four questions), potential disruption of healthcare (12 questions), and influence of the COVID-19 pandemic on the particular physician (four questions). A matrix with four different response options was created for the particular surgical procedures). Results One hundred forty-nine physicians from five continents completed the survey. Of the respondents, 20.1% and 20.7% stated that surgery for life-threatening sarcomas were stopped or delayed, respectively. Even when the malignancy was expected to involve infiltration of a neurovascular bundle or fracture of a bone, still 13.8% and 14.7% of the respondents, respectively, stated that surgery was not performed. In cases of pending fractures of bone tumors, 37.5 to 46.2% of operations were canceled. Conclusion The SARS-CoV-2 pandemic caused a significant reduction in healthcare (surgery, radiotherapy, chemotherapy) for malignancies of the musculoskeletal system. Delaying or stopping these treatments is life-threatening or can cause severe morbidity, pain, and loss of function. Although the coronavirus disease causes severe medical complications, serious collateral damage including death due to delayed or untreated sarcomas should be avoided.
    Keywords Musculoskeletal tumor . Oncology . COVID-19 . Healthcare . Pandemic . Sarcoma . Severe acute respiratory syndrome coronavirus 2 . SARS-CoV-2 ; covid19
    Subject code 610
    Language English
    Publishing country it
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article: Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours

    Thaler, Martin / Khosravi, Ismail / Leithner, Andreas / Papagelopoulos, Panayiotis J / Ruggieri, Pietro

    Int Orthop

    Abstract: ... COVID-19) pandemic on musculoskeletal tumor service by conducting an online survey of physicians ... potential disruption of healthcare (12 questions), and influence of the COVID-19 pandemic on the particular ... for malignancies of the musculoskeletal system. Delaying or stopping these treatments is life-threatening or ...

    Abstract BACKGROUND: The aim of the current study was to evaluate the impact of the coronavirus disease (COVID-19) pandemic on musculoskeletal tumor service by conducting an online survey of physicians. METHODS: The survey was conducted among the members of the ISOLS (International Society of Limb Salvage) and the EMSOS (European Musculo-Skeletal Oncology Society). The survey consisted of 20 questions (single, multiple-response, ranked): origin and surgical experience of the participant (four questions), potential disruption of healthcare (12 questions), and influence of the COVID-19 pandemic on the particular physician (four questions). A matrix with four different response options was created for the particular surgical procedures). RESULTS: One hundred forty-nine physicians from five continents completed the survey. Of the respondents, 20.1% and 20.7% stated that surgery for life-threatening sarcomas were stopped or delayed, respectively. Even when the malignancy was expected to involve infiltration of a neurovascular bundle or fracture of a bone, still 13.8% and 14.7% of the respondents, respectively, stated that surgery was not performed. In cases of pending fractures of bone tumors, 37.5 to 46.2% of operations were canceled. CONCLUSION: The SARS-CoV-2 pandemic caused a significant reduction in healthcare (surgery, radiotherapy, chemotherapy) for malignancies of the musculoskeletal system. Delaying or stopping these treatments is life-threatening or can cause severe morbidity, pain, and loss of function. Although the coronavirus disease causes severe medical complications, serious collateral damage including death due to delayed or untreated sarcomas should be avoided.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #361500
    Database COVID19

    Kategorien

To top